Literature DB >> 30648620

T-type calcium channels: From molecule to therapeutic opportunities.

Norbert Weiss1, Gerald W Zamponi2.   

Abstract

T-type calcium channels serve an essential role in the functioning of the nervous system. They exhibit unique properties among voltage-gated calcium channels, and mediate specific roles in brain function. Over the recent years, it has come to light that a number of chronic neurological disorders arise from defects in T-type channel function. The question then arises as to whether T-type channels could represent a relevant druggable target. In this review, we introduce the diversity, molecular structure, and principal electrophysiological properties of T-type channels. Then, we highlight their role in neuronal development, and their pathophysiological role in the nervous system. Finally, we discuss the potential of T-type channels as therapeutic targets in light of recent advances in their pharmacopoeia.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ca(v)3 channel; Calcium; Epilepsy; Neuron; Pain; T-type channel

Mesh:

Substances:

Year:  2019        PMID: 30648620     DOI: 10.1016/j.biocel.2019.01.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  23 in total

1.  Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic Drug.

Authors:  Muriel Richard; Priska Kaufmann; Marion Ort; Rüdiger Kornberger; Jasper Dingemanse
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

2.  Contribution of T-Type Calcium Channels to Spinal Cord Injury-Induced Hyperexcitability of Nociceptors.

Authors:  Justas Lauzadis; Huilin Liu; Yong Lu; Mario J Rebecchi; Martin Kaczocha; Michelino Puopolo
Journal:  J Neurosci       Date:  2020-08-24       Impact factor: 6.167

3.  Selective inhibition of neuronal Cav3.3 T-type calcium channels by TAT-based channel peptide.

Authors:  Leos Cmarko; Norbert Weiss
Journal:  Mol Brain       Date:  2020-06-19       Impact factor: 4.041

4.  Compound heterozygous CACNA1H mutations associated with severe congenital amyotrophy.

Authors:  Melissa T Carter; Hugh J McMillan; Andriy Tomin; Norbert Weiss
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

Review 5.  Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?

Authors:  Francesca Boscia; Maria Louise Elkjaer; Zsolt Illes; Maria Kukley
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

Review 6.  Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

Authors:  Alexei M Bygrave; Kasyoka Kilonzo; Dimitri M Kullmann; David M Bannerman; Dennis Kätzel
Journal:  Front Psychiatry       Date:  2019-11-21       Impact factor: 4.157

Review 7.  Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).

Authors:  Francesca Prestori; Francesco Moccia; Egidio D'Angelo
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

8.  A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity.

Authors:  Robin N Stringer; Bohumila Jurkovicova-Tarabova; Sun Huang; Omid Haji-Ghassemi; Romane Idoux; Anna Liashenko; Ivana A Souza; Yuriy Rzhepetskyy; Lubica Lacinova; Filip Van Petegem; Gerald W Zamponi; Roger Pamphlett; Norbert Weiss
Journal:  Mol Brain       Date:  2020-03-06       Impact factor: 4.041

9.  Functional identification of potential non-canonical N-glycosylation sites within Cav3.2 T-type calcium channels.

Authors:  Vendula Ficelova; Ivana A Souza; Leos Cmarko; Maria A Gandini; Robin N Stringer; Gerald W Zamponi; Norbert Weiss
Journal:  Mol Brain       Date:  2020-11-11       Impact factor: 4.041

Review 10.  Calcium, Bioenergetics, and Parkinson's Disease.

Authors:  Enrico Zampese; D James Surmeier
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.